| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |